U.S. Ciena, Huntsman, Prog Holdings
June 7 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Ciena, Huntsman and Prog Holdings, on Friday.
HIGHLIGHTS
* Capital One Financial Corp COF.N: BTIG initiates coverage with neutral rating |
* Ciena Corp CIEN.N: Raymond James cuts to outperform from strong buy |
* Collegium Pharmaceutical Inc COLL.O: Jefferies raises to buy from hold |
* Huntsman Corp HUN.N: JP Morgan raises to overweight from underweight |
* Prog Holdings Inc PRG.N: BTIG initiates coverage with neutral rating |
Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical order.
* 2Seventy Bio Inc TSVT.O: Goldman Sachs cuts target price to $2 from $5 |
* 3M Co MMM.N: BofA Global Research raises price objective to $120 from $105 |
* 3M Co MMM.N: BofA Global Research raises to buy from neutral |
* Aaron's Company Inc AAN.N: BTIG initiates coverage with neutral rating |
* Abm Industries Inc ABM.N: Deutsche Bank raises target price to $53 from $49 |
* Abm Industries Inc ABM.N: Truist Securities raises target price to $49 from $45 |
* Abm Industries Inc ABM.N: UBS raises target price to $51 from $45 |
* Acco Brands Corp ACCO.N: Barrington Research cuts target price to $7 from $7.5 |
* Addus Homecare Corp ADUS.O: Oppenheimer raises target price to $130 from $118 |
* Adobe Inc ADBE.O: Mizuho cuts target price to $640 from $680 |
* Adobe Inc ADBE.O: Stifel cuts target price to $600 from $625 |
* Affirm Holdings Inc AFRM.O: BTIG assumes coverage with neutral rating |
* Ally Financial Inc ALLY.N: BTIG initiates coverage with buy rating; price target $51 |
* American Express Co AXP.N: BTIG initiates coverage with neutral rating |
* America's Car-Mart Inc CRMT.O: BTIG initiates coverage with neutral rating |
* Annaly Capital Management Inc NLY.N: UBS raises target price to $20.5 from $19.5 |
* Armour Residential REIT Inc ARR.N: UBS raises target price to $19 from $18 |
* Atlanticus Holdings Corp ATLC.O: BTIG initiates coverage with buy rating; PT $45 |
* Avenue Therapeutics Inc ATXI.O: Maxim Group cuts PT to $12 from $56.25 to reflect 1-for-75 reverse stock split |
* Avery Dennison Corp AVY.N: Baird raises target price to $250 from $230 |
* Banzai International Inc BNZI.O: Ascendiant Capital Markets raises PT to $3.25 from $3 |
* Big Lots Inc BIG.N: Telsey Advisory Group cuts target price to $2.5 from $5 |
* Biomea Fusion Inc BMEA.O: Citigroup cuts target price to $45 from $90 |
* Biomea Fusion Inc BMEA.O: H.C. Wainwright cuts target price to $15 from $50 |
* Biomea Fusion Inc BMEA.O: Scotiabank cuts target price to $21 from $41 |
* Boeing BA.N: UBS cuts target price to $240 from $250 |
* Braze Inc BRZE.O: JP Morgan cuts target price to $55 from $58 |
* Braze Inc BRZE.O: Raymond James cuts target price to $55 from $65 |
* Bread Financial Holdings Inc BFH.N: BTIG initiates coverage with neutral rating |
* Brown-Forman Corp BFb.N: TD Cowen cuts target price to $50 from $65 |
* Campbell Soup Co CPB.N: Stephens raises target price to $51 from $50 |
* Capital One Financial Corp COF.N: BTIG initiates coverage with neutral rating |
* Chargepoint Holdings Inc CHPT.N: UBS cuts target price to $2 from $2.25 |
* Charles River Laboratories International Inc CRL.N: Mizuho initiates with $235 PT |
* Charles River Laboratories International Inc CRL.N: Mizuho initiates with neutral rating |
* Chemours Co CC.N: Mizuho initiates with neutral rating and $25 PT |
* Ciena Corp CIEN.N: Northland Capital raises target price to $46 |
* Ciena Corp CIEN.N: Raymond James cuts target price to $54 from $59 |
* Ciena Corp CIEN.N: Raymond James cuts to outperform from strong buy |
* Collegium Pharmaceutical Inc COLL.O: Jefferies raises target price to $44 from $41 |
* Collegium Pharmaceutical Inc COLL.O: Jefferies raises to buy from hold |
* Comscore Inc SCOR.O: Needham cuts target price to $17 from $25 |
* Concrete Pumping Holdings Inc BBCP.O: Stifel cuts target price to $8 from $9 |
* Couchbase Inc BASE.O: Goldman Sachs cuts target price to $18 from $30 |
* Couchbase Inc BASE.O: Goldman Sachs cuts to sell from neutral |
* Discover Financial Services DFS.N: BTIG initiates coverage with neutral rating |
* Docusign Inc DOCU.O: BofA Global Research cuts price objective to $60 from $72 |
* Docusign Inc DOCU.O: Morgan Stanley cuts target price to $62.00 from $65.00 |
* Docusign Inc DOCU.O: RBC cuts target price to $52 from $59 |
* Docusign Inc DOCU.O: UBS cuts target price to $56 from $62 |
* Dollar Tree Inc DLTR.O: Citigroup cuts to neutral from buy; cuts PT to $120 from $163 |
* Dollar Tree Inc DLTR.O: Deutsche Bank cuts target price to $149 from $151 |
* Duckhorn Portfolio Inc NAPA.N: BMO cuts target price to $9 from $10 |
* Duckhorn Portfolio Inc NAPA.N: Citigroup cuts target price to $10 from $11 |
* Duos Technologies Group Inc DUOT.O: Ascendiant Capital Markets cuts PT to $5.75 from $6 |
* Eli Lilly LLY.N: Jefferies raises target price to $957 from $925 |
* Emerson EMR.N: HSBC raises target price to $132 from $114 |
* Endra Life Sciences Inc NDRA.O: Ascendiant Capital Markets cuts target to $8 from $10 |
* Exxon Mobil XOM.N: Truist Securities cuts target price to $124 from $146 |
* Exxon Mobil XOM.N: Truist Securities cuts to hold from buy |
* Firstcash Holdings Inc FCFS.O: BTIG initiates coverage with neutral rating |
* Five Below Inc FIVE.O: Deutsche Bank cuts target price to $155 from $177 |
* Ftai Aviation Ltd FTAI.O: Deutsche Bank raises target price to $100 from $90 |
* Ftai Aviation Ltd FTAI.O: RBC raises target price to $95 from $85 |
* Gen Digital Inc GEN.O: Morgan Stanley cuts target price to $27.00 from $28.00 |
* Gen Digital Inc GEN.O: Morgan Stanley cuts to equal-weight from overweight |
* Geron Corp GERN.O: Needham raises target price to $6 from $5 |
* Greif Inc GEF.N: Wells Fargo raises target price to $80 from $78 |
* Halozyme Therapeutics Inc HALO.O: Leerink Partners raises target price to $53 from $45 |
* Halozyme Therapeutics Inc HALO.O: TD Cowen raises target price to $59 from $54 |
* HCA Healthcare Inc HCA.N: Jefferies raises target price to $390 from $350 |
* Healthequity Inc HQY.O: Raymond James raises target price to $105 from $100 |
* Herc Holdings Inc HRI.N: JP Morgan initiates coverage with neutral rating; PT $155 |
* Huntsman Corp HUN.N: JP Morgan raises target price to $27 from $22 |
* Huntsman Corp HUN.N: JP Morgan raises to overweight from underweight |
* Insmed Inc INSM.O: Mizuho raises target price to $82 from $36 |
* International Flavors & Fragrances IFF.N: Oppenheimer initiates coverage with outperform rating |
* International Flavors & Fragrances IFF.N: Oppenheimer initiates coverage with PT $116 |
* Invesco Mortgage Capital Inc IVR.N: UBS raises target price to $9 from $8.5 |
* J M Smucker Co SJM.N: Citigroup raises target price to $139 from $137 |
* J M Smucker Co SJM.N: JP Morgan raises target price to $122 from $120 |
* J M Smucker Co SJM.N: TD Cowen cuts target price to $135 from $140 |
* Kla Corp KLAC.O: Raymond James raises target price to $875 from $750 |
* Korn Ferry KFY.N: UBS raises target price to $68 from $66 |
* Lam Research Corp LRCX.O: Berenberg raises target price to $1150 from $960 |
* Lam Research Corp LRCX.O: Raymond James raises target price to $1,060 from $950 |
* Legalzoom.Com Inc LZ.O: JP Morgan cuts target price to $14 from $15 |
* Lendingclub Corp LC.N: BTIG initiates coverage with buy rating; price target $12 |
* Lyft Inc LYFT.O: BMO raises target price to $19 from $18 |
* Lyft Inc LYFT.O: BofA Global Research raises price objective to $20 from $15 |
* Lyft Inc LYFT.O: BofA Global Research raises to buy from underperform |
* Lyft Inc LYFT.O: Goldman Sachs raises target price to $21 from $19 |
* Lyft Inc LYFT.O: Morgan Stanley raises target price to $18 from $17 |
* Lyft Inc LYFT.O: TD Cowen raises target price to $18 from $16 |
* Lyft Inc LYFT.O: Wedbush raises target price to $19 from $18 |
* Microsoft MSFT.O: Oppenheimer raises target price to $500 from $450 |
* Moderna MRNA.O: Jefferies raises target price to $180 from $155 |
* Nio Inc NIO.N: JP Morgan cuts target price to $5.3 from $5.4 |
* Northrop Grumman NOC.N: Jefferies cuts target price to $500 from $530 |
* ON Holding AG ONON.N: Telsey Advisory Group raises target price to $47 from $40 |
* Onemain Holdings Inc OMF.N: BTIG initiates coverage with neutral rating |
* Open Lending Corp LPRO.O: BTIG assumes coverage with neutral rating |
* Pediatrix Medical Group Inc MD.N: Deutsche Bank raises to hold from sell |
* Planet Labs, Inc. PL.N: Craig-Hallum cuts target price to $2 from $3 |
* Powerschool Holdings Inc PWSC.N: Needham cuts to hold from buy |
* Prog Holdings Inc PRG.N: BTIG initiates coverage with neutral rating |
* PVH Corp PVH.N: TD Cowen raises target price to $154 from $153 |
* Relay Therapeutics Inc RLAY.O: Leerink Partners raises target price to $19 from $18 |
* Rent the Runway Inc RENT.O: Jefferies raises target price to $34 from $21 |
* Replimune Group Inc REPL.O: H.C. Wainwright raises target price to $17 from $12 |
* Samsara Inc IOT.N: Evercore ISI cuts target price to $40 from $41 |
* Samsara Inc IOT.N: Truist Securities cuts target price to $35 from $38 |
* Seres Therapeutics Inc MCRB.O: Chardan Capital Markets cuts target to $1.25 from $6 |
* Seres Therapeutics Inc MCRB.O: Oppenheimer cuts to perform from outperform |
* Skechers USA Inc SKX.N: BofA Global Research raises price objective to $87 from $71 |
* Skechers USA Inc SKX.N: BofA Global Research raises to buy from neutral |
* Sofi Technologies Inc SOFI.O: BTIG assumes coverage with neutral rating |
* Structure Therapeutics Inc GPCR.O: BMO raises target price to $100 from $83 |
* Sunoco LP SUN.N: Stifel raises to buy from hold |
* Sweetgreen Inc SG.N: RBC raises target price to $45 from $35 |
* Synchrony Financial SYF.N: BTIG initiates coverage with buy rating; price target $60 |
* Take-Two Interactive Software Inc TTWO.O: Deutsche Bank raises PT to $190 from $180 |
* Targa Resources Corp TRGP.N: JP Morgan raises target price to $140 from $130 |
* Texas Roadhouse Inc TXRH.O: RBC raises target price to $175 from $165 |
* Third Harmonic Bio Inc THRD.O: Raymond James initiates coverage with outperform rating |
* Third Harmonic Bio Inc THRD.O: Raymond James initiates coverage with target price $18 |
* Tillys Inc TLYS.N: Roth MKM cuts target price to $6 from $7.5 |
* Toro Co TTC.N: D.A. Davidson raises target price to $103 from $95 |
* Toro Co TTC.N: Northland Capital raises target price to $100 from $95 |
* Transdigm Group Inc TDG.N: Jefferies raises PT to $1,625 from $1,520 |
* Transmedics Group Inc TMDX.O: TD Cowen raises target price to $175 from $130 |
* Tronox Holdings Plc TROX.N: Mizuho initiates with neutral rating and $22 price target |
* Two Harbors Investment Corp TWO.N: UBS raises target price to $14.5 from $13.5 |
* Two Harbors Investment Corp TWO.N: UBS raises to buy from neutral |
* Ultragenyx Pharmaceutical Inc RARE.O: Goldman Sachs raises target price to $67 from $56 |
* United Natural Foods Inc UNFI.N: Jefferies raises target price to $14 from $13.5 |
* United Rentals Inc URI.N: JP Morgan initiates coverage with overweight rating; PT $780 |
* Upbound Group Inc UPBD.O: BTIG initiates coverage with buy rating; price target $45 |
* Upstart Holdings Inc UPST.O: BTIG assumes coverage with sell rating; price target $14 |
* Vail Resorts Inc MTN.N: BofA Global Research cuts price objective to $195 from $230 |
* Vail Resorts Inc MTN.N: Deutsche Bank cuts target price to $218 from $226 |
* Vail Resorts Inc MTN.N: Jefferies cuts target price to $190 from $225 |
* Vail Resorts Inc MTN.N: JP Morgan cuts target price to $176 from $217 |
* Vail Resorts Inc MTN.N: JP Morgan cuts to underweight from neutral |
* Vail Resorts Inc MTN.N: Mizuho cuts target price to $231 from $256 |
* Vail Resorts Inc MTN.N: Morgan Stanley cuts target price to $179.00 from $229.00 |
* Vail Resorts Inc MTN.N: Stifel cuts target price to $259 from $262 |
* Vail Resorts Inc MTN.N: Truist Securities cuts target price to $250 from $265 |
* Veeco Instruments Inc VECO.O: Northland Capital raises target price to $53 |
* Victoria's Secret & Co VSCO.N: Barclays raises target price to $19 from $16 |
* Victoria's Secret & Co VSCO.N: Telsey Advisory Group raises PT to $24 from $20 |
* Wynn Resorts Ltd WYNN.O: UBS raises target price to $114 from $105 |
* Zumiez Inc ZUMZ.O: Jefferies raises target price to $19 from $14 |
(Compiled by Bengaluru Newsroom)
</body></html>Ativos relacionados
Últimas notícias
Isenção de Responsabilidade: As entidades do XM Group proporcionam serviço de apenas-execução e acesso à nossa plataforma online de negociação, permitindo a visualização e/ou uso do conteúdo disponível no website ou através deste, o que não se destina a alterar ou a expandir o supracitado. Tal acesso e uso estão sempre sujeitos a: (i) Termos e Condições; (ii) Avisos de Risco; e (iii) Termos de Responsabilidade. Este, é desta forma, fornecido como informação generalizada. Particularmente, por favor esteja ciente que os conteúdos da nossa plataforma online de negociação não constituem solicitação ou oferta para iniciar qualquer transação nos mercados financeiros. Negociar em qualquer mercado financeiro envolve um nível de risco significativo de perda do capital.
Todo o material publicado na nossa plataforma de negociação online tem apenas objetivos educacionais/informativos e não contém — e não deve ser considerado conter — conselhos e recomendações financeiras, de negociação ou fiscalidade de investimentos, registo de preços de negociação, oferta e solicitação de transação em qualquer instrumento financeiro ou promoção financeira não solicitada direcionadas a si.
Qual conteúdo obtido por uma terceira parte, assim como o conteúdo preparado pela XM, tais como, opiniões, pesquisa, análises, preços, outra informação ou links para websites de terceiras partes contidos neste website são prestados "no estado em que se encontram", como um comentário de mercado generalizado e não constitui conselho de investimento. Na medida em que qualquer conteúdo é construído como pesquisa de investimento, deve considerar e aceitar que este não tem como objetivo e nem foi preparado de acordo com os requisitos legais concebidos para promover a independência da pesquisa de investimento, desta forma, deve ser considerado material de marketing sob as leis e regulações relevantes. Por favor, certifique-se que leu e compreendeu a nossa Notificação sobre Pesquisa de Investimento não-independente e o Aviso de Risco, relativos à informação supracitada, os quais podem ser acedidos aqui.
